| UniProt ID | FADD_HUMAN | |
|---|---|---|
| UniProt AC | Q13158 | |
| Protein Name | FAS-associated death domain protein | |
| Gene Name | FADD | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 208 | |
| Subcellular Localization | ||
| Protein Description | Apoptotic adaptor molecule that recruits caspase-8 or caspase-10 to the activated Fas (CD95) or TNFR-1 receptors. The resulting aggregate called the death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation. Active caspase-8 initiates the subsequent cascade of caspases mediating apoptosis. Involved in interferon-mediated antiviral immune response, playing a role in the positive regulation of interferon signaling.. | |
| Protein Sequence | MDPFLVLLHSVSSSLSSSELTELKFLCLGRVGKRKLERVQSGLDLFSMLLEQNDLEPGHTELLRELLASLRRHDLLRRVDDFEAGAAAGAAPGEEDLCAAFNVICDNVGKDWRRLARQLKVSDTKIDSIEDRYPRNLTERVRESLRIWKNTEKENATVAHLVGALRSCQMNLVADLVQEVQQARDLQNRSGAMSPMSWNSDASTSEAS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDPFLVLL -------CCHHHHHH | 15.48 | - | |
| 10 | Phosphorylation | PFLVLLHSVSSSLSS HHHHHHHHHCCCCCC | 24.54 | 20068231 | |
| 12 | Phosphorylation | LVLLHSVSSSLSSSE HHHHHHHCCCCCCCH | 19.75 | 20068231 | |
| 13 | Phosphorylation | VLLHSVSSSLSSSEL HHHHHHCCCCCCCHH | 32.89 | 20068231 | |
| 14 | Phosphorylation | LLHSVSSSLSSSELT HHHHHCCCCCCCHHH | 25.43 | 20068231 | |
| 16 | Phosphorylation | HSVSSSLSSSELTEL HHHCCCCCCCHHHHH | 33.49 | 20068231 | |
| 17 | Phosphorylation | SVSSSLSSSELTELK HHCCCCCCCHHHHHH | 32.88 | 20068231 | |
| 18 | Phosphorylation | VSSSLSSSELTELKF HCCCCCCCHHHHHHH | 33.00 | 20068231 | |
| 21 | Phosphorylation | SLSSSELTELKFLCL CCCCCHHHHHHHHHH | 34.91 | 20068231 | |
| 41 | Phosphorylation | RKLERVQSGLDLFSM HHHHHHHHHHHHHHH | 38.17 | 21082442 | |
| 47 | Phosphorylation | QSGLDLFSMLLEQND HHHHHHHHHHHHCCC | 18.80 | 28464451 | |
| 69 | Phosphorylation | LLRELLASLRRHDLL HHHHHHHHHHHHHHH | 23.52 | 24719451 | |
| 120 | Sumoylation | RRLARQLKVSDTKID HHHHHHCCCCCCCCC | 31.21 | - | |
| 125 | Ubiquitination | QLKVSDTKIDSIEDR HCCCCCCCCCCHHHH | 49.89 | 33845483 | |
| 125 | Sumoylation | QLKVSDTKIDSIEDR HCCCCCCCCCCHHHH | 49.89 | - | |
| 128 | Phosphorylation | VSDTKIDSIEDRYPR CCCCCCCCHHHHCCC | 31.20 | 25278378 | |
| 132 | Methylation | KIDSIEDRYPRNLTE CCCCHHHHCCCCHHH | 30.48 | - | |
| 133 | Phosphorylation | IDSIEDRYPRNLTER CCCHHHHCCCCHHHH | 20.90 | 25278378 | |
| 138 | Phosphorylation | DRYPRNLTERVRESL HHCCCCHHHHHHHHH | 25.87 | 25278378 | |
| 149 | Sumoylation | RESLRIWKNTEKENA HHHHHHHHCCCCCHH | 52.17 | - | |
| 149 | Ubiquitination | RESLRIWKNTEKENA HHHHHHHHCCCCCHH | 52.17 | 29967540 | |
| 153 | Ubiquitination | RIWKNTEKENATVAH HHHHCCCCCHHHHHH | 54.98 | 29967540 | |
| 157 | Phosphorylation | NTEKENATVAHLVGA CCCCCHHHHHHHHHH | 29.79 | - | |
| 166 | Methylation | AHLVGALRSCQMNLV HHHHHHHHHHHHHHH | 34.55 | - | |
| 167 | Phosphorylation | HLVGALRSCQMNLVA HHHHHHHHHHHHHHH | 15.00 | - | |
| 168 | Glutathionylation | LVGALRSCQMNLVAD HHHHHHHHHHHHHHH | 3.44 | 22555962 | |
| 170 | Sulfoxidation | GALRSCQMNLVADLV HHHHHHHHHHHHHHH | 4.99 | 28465586 | |
| 190 | Phosphorylation | ARDLQNRSGAMSPMS HHHHHHCCCCCCCCC | 38.15 | 23927012 | |
| 194 | Phosphorylation | QNRSGAMSPMSWNSD HHCCCCCCCCCCCCC | 19.54 | 20201521 | |
| 197 | Phosphorylation | SGAMSPMSWNSDAST CCCCCCCCCCCCCCC | 26.87 | 23927012 | |
| 200 | Phosphorylation | MSPMSWNSDASTSEA CCCCCCCCCCCCCCC | 28.44 | 23403867 | |
| 203 | Phosphorylation | MSWNSDASTSEAS-- CCCCCCCCCCCCC-- | 37.14 | 21978935 | |
| 204 | Phosphorylation | SWNSDASTSEAS--- CCCCCCCCCCCC--- | 32.10 | 23403867 | |
| 205 | Phosphorylation | WNSDASTSEAS---- CCCCCCCCCCC---- | 28.77 | 23403867 | |
| 208 | Phosphorylation | DASTSEAS------- CCCCCCCC------- | 36.38 | 23403867 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 194 | S | Phosphorylation | Kinase | HIPK3 | Q9H422 | PhosphoELM |
| 194 | S | Phosphorylation | Kinase | CSNK1A1 | P48729 | GPS |
| 194 | S | Phosphorylation | Kinase | CK1A | P97633 | PSP |
| 194 | S | Phosphorylation | Kinase | MAP3K1 | Q13233 | GPS |
| 194 | S | Phosphorylation | Kinase | MAP2K7 | O14733 | GPS |
| 194 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| 200 | S | Phosphorylation | Kinase | CK2B | P67870 | PSP |
| 203 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FADD_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FADD_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 613759 | Infections, recurrent, associated with encephalopathy, hepatic dysfunction and cardiovascular malformations (IEHDCM) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-194 AND SER-197, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-194, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-194 AND SER-197, AND MASS SPECTROMETRY. | |
| "FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase thatinduces FADD phosphorylation and inhibits Fas-mediated Jun NH2-terminal kinase activation."; Rochat-Steiner V., Becker K., Micheau O., Schneider P., Burns K.,Tschopp J.; J. Exp. Med. 192:1165-1174(2000). Cited for: IDENTIFICATION IN A COMPLEX WITH HIPK3 AND FAS, AND PHOSPHORYLATION ATSER-194. | |